A neuroendovascular non-coil is used to treat an unruptured or ruptured brain aneurysm (a weakened area in the artery wall). The treatment is either known as endovascular coiling or endovascular embolization. During this procedure, the neuroendovascular non-coil blocks the blood flow in an aneurysm. The treatment is usually performed under general anesthesia by interventional neuroradiologists using fluoroscopic imaging guidance. Neuroendovascular non-coils are used as alternatives to coils in the treatment of an aneurysm.
Publisher’s analysts forecast the global neuroendovascular non-coils market to grow at a CAGR of 12.9% during the period 2016-2020.
For more information about this report: http://www.reportsweb.com/global-neuroendovascular-non-coils-market-2016-2020
Covered in this report
The report covers the present scenario and the growth prospects of the global neuroendovascular non-coils market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of medical devices required for thoracic surgeries.
The market is divided into the following segments based on geography:
Publisher’s report, Global Neuroendovascular Non-coils Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
- Boston Scientific
- St. Jude Medical
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001438259/sample
Other prominent vendors
- AdvanSource Biomaterials
- AGA Medical
- Allium Medical
- Atrium Medical
- Biophan Technologies
- Biosense Webster
- Cardiac Science
- Dextera Surgical
- Claret Medical
- Contego Medical
- Cook Group
- Innovative Cardiovascular Solutions
- Keystone Heart
- St. Jude Medical
- Transverse Medical
Inquire for Report at http://www.reportsweb.com/inquiry&RW0001438259/buying